{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-034724","form_type":"8-K","ticker":"JUNS","cik":"0001679628","company_name":"JUPITER NEUROSCIENCES, INC.","filed_at":"2026-07-27T13:00:41+00:00","discovered_at":"2026-07-27T13:02:00.407818+00:00","generated_at":"2026-07-27T13:02:15.477849+00:00","sec_items":["5.07","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Jupiter Neurosciences shareholders approve reverse stock split (1:10-1:100) and 5.25M share equity plan increase","bullets":["Shareholders approved reverse stock split at ratio between 1:10 and 1:100, with board discretion on timing and ratio.","Equity incentive plan amended to increase authorized shares by 5,250,000 shares.","All seven director nominees elected; Cherry Bekaert ratified as auditor for FY2026.","Under SEPA with Yorkville, ~$1.5M convertible notes outstanding; ~12.5M shares issued for ~$4.1M net proceeds."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-034724","json":"https://secwatch.observer/filing/0001493152-26-034724.json","markdown":"https://secwatch.observer/filing/0001493152-26-034724.md","text":"https://secwatch.observer/filing/0001493152-26-034724.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1679628/000149315226034724/0001493152-26-034724-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1679628/000149315226034724/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-27T13:02:15.477849+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}